BeStock  
Markets › Compare › HLN vs TEVA

HLN vs TEVA

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
HLN · Haleon$8.74 ▼ 2.94%
TEVA · Teva Pharmaceutical Industries$39.16 ▼ 1.11%

Head to head

MetricHLNTEVA
Price$8.74$39.16
Change today▼ 2.94%▼ 1.11%
Market cap$38.41B$45.67B
Return, 3 months––
Return, year to date––
Return, 1 year––
P/E (TTM)18.265.3
P/B1.85.9
P/E percentile vs own 5y10th100th
Dividend yield2.18%–
Revenue growth (YoY, latest qtr)-0.3%-0.8%
Net profit growth (YoY)+3,071.4%-303.2%
Gross margin65.0%52.5%
Operating margin21.4%18.7%
Net margin14.6%4.1%
Return on equity10.0%9.7%
Analyst target vs. price+25.9%+14.9%
Analyst buy share100%100%
RSI (14)––
30-day volatility––
Max drawdown, 1 year––
Trend read––
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • TEVA is the largest of the group by market value.
  • HLN carries the lowest trailing P/E.
  • HLN is growing revenue fastest.
  • HLN keeps the most profit per dollar of sales.

Go deeper

Scroll to Top